Assignee
CT INGENIERIA GENETICA BIOTECNOLOGIA
CU·12 granted patents·21 pending applications·3 citations·filing 2013–2023
Top patents by PatentIndex Score
33 records- 0172US10131927B2Method for obtaining 1-kestoseCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2013·Granted Nov 20, 2018·3 cites·3 claims
- 0266US2024316147A1Pharmaceutical composition comprising an apl type peptideCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2023·Application pending·0 cites
- 0364US11759517B2Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virusCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Granted Sep 19, 2023·0 cites·3 claims
- 0458US11564975B2Use of GHRP-6 as late cardioprotective and cardiac restoration medicamentCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2019·Granted Jan 31, 2023·0 cites·7 claims
- 0558US2022259300A1Vaccine composition comprising a mutant of human interleukin-15CT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 0657US11013235B2Method for treating diseases in plantsCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2020·Granted May 25, 2021·0 cites·17 claims
- 0756US2024317827A1Linear peptides inhibiting ck2-mediated phosphorylation and compositions comprising sameCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Application pending·0 cites
- 0853US11491218B2Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virusCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2017·Granted Nov 8, 2022·0 cites·4 claims
- 0953US2022272986A1Biopesticide and biofertilizer compositionCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2020·Application pending·0 cites
- 1052US2024139105A1Pharmaceutical composition containing ghrp-6CT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Application pending·0 cites
- 1151US10993438B2Method for treating diseases in plantsCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2016·Granted May 4, 2021·0 cites·17 claims
- 1251US2022030877A1Solid composition for agricultural and veterinary useCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2019·Application pending·0 cites
- 1350US9603900B2Use of PACAP for the treatment of viral infections in aquatic organismsCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2015·Granted Mar 28, 2017·0 cites·11 claims
- 1450US2024350611A1Recombinant antigen for inducing an immune response against the zika virusCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Application pending·0 cites
- 1549US2020181254A1Vaccine composition comprising a mutant of human interleukin-15CT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2017·Application pending·0 cites
- 1649US2025326826A1Polypeptides that bind proangiogenic growth factorsCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Application pending·0 cites
- 1748US12297246B2Interleukin-15 activity antagonist peptideCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2018·Granted May 13, 2025·0 cites·2 claims
- 1848US11510965B2Vesicles comprising epidermal growth factor and compositions thereofCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2017·Granted Nov 29, 2022·0 cites·23 claims
- 1947US2023190866A1Peptide for the treatment of cytokine storm syndromeCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2047US2023390369A1Chimeric antigen comprising the extracellular domain of pd-l1CT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2147US2023405106A1Chimeric protein comprising the receptor binding domain of the corona virus spike protein and compositions comprising themCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2246US2025282828A1Peptides for the treatment of respiratory infections of viral originCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2346US2024082392A1Use of synthetic peptide for the induction of antitumor and antiviral immunityCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2445US2021196793A1Pharmaceutical Combination Comprising Epidermal Growth Factor and Secretagogue Peptide GHRP6 for the Restoration of Brain DamageCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2019·Application pending·0 cites
- 2545US2022168391A1Use of epidermal growth factor in diabetic foot ulcer treatmentCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2020·Application pending·0 cites
- 2643US2020353040A1Pharmaceutical Composition Comprising an APL Type PeptideCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2018·Application pending·0 cites
- 2743US2023046501A1Polypeptides comprising mutated forms of human vegf-a with rearrangements of disulfide bonds and compositions containing sameCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2020·Application pending·0 cites
- 2838US10765341B2Feet positioning system for magnetic resonance imaging studiesCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2014·Granted Sep 8, 2020·0 cites·7 claims
- 2937US10434137B2Method for inhibiting HIV replication in mammal and human cellsCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2015·Granted Oct 8, 2019·0 cites·4 claims
- 3035US2017119733A1Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseasesCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2016·Application pending·0 cites
- 3131US2018256112A1Stereotactic frame for limbsCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2016·Application pending·0 cites
- 3223US11917966B2Soy plants comprising the transgenic event CIGBDT-DEF1 or CIGBIS-DEF5CT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2018·Granted Mar 5, 2024·0 cites·13 claims
- 3316US2016317674A1Conjugate comprising erythropoietin and a branched polymer structureCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CT INGENIERIA GENETICA BIOTECNOLOGIA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →